Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Kemp

Showing results (1-10 of 107) with videos related to

Pageof 11
Sort By:
Brain Pathology (Zurich, Switzerland)|July 15, 2010
Biochemical aspects of X-linked adrenoleukodystrophyStephan Kemp, Ronald Wanders
JAMA Pediatrics|February 10, 2025
Newborn Screening for AdrenoleukodystrophyMarc Engelen, Stephan Kemp
Handbook of Clinical Neurology|July 16, 2021
Endocrine dysfunction in adrenoleukodystrophyMarc Engelen, Stephan Kemp, Florian Eichler
European Journal of Human Genetics : EJHG|November 11, 2011
Clinical utility gene card for: adrenoleukodystrophyErnst Krasemann, Stephan Kemp, Andreas Gal
Molecular Genetics and Metabolism|November 10, 2006
X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatmentStephan Kemp, Ronald J A Wanders
Biochimica Et Biophysica Acta|April 10, 2012
X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspectsStephan Kemp, Johannes Berger, Patrick Aubourg
Handbook of Clinical Neurology|September 25, 2024
AdrenoleukodystrophyMarc Engelen, Stephan Kemp, Florian Eichler
The FEBS Journal|December 16, 2010
Fatty acid omega-oxidation as a rescue pathway for fatty acid oxidation disorders in humansRonald J A Wanders, Jasper Komen, Stephan Kemp
Current Neurology and Neuroscience Reports|August 14, 2014
X-linked adrenoleukodystrophy: pathogenesis and treatmentMarc Engelen, Stephan Kemp, Bwee-Tien Poll-The
Cells|January 21, 2022
Structure and Function of the <i>ABCD1</i> Variant Database: 20 Years, 940 Pathogenic Variants, and 3400 Cases of AdrenoleukodystrophyEric J Mallack, Kerry Gao, Marc Engelen, et al.
Pageof 11

Showing results (1-10 of 107) with videos related to

Sort By:
Pageof 11
Brain Pathology (Zurich, Switzerland)|July 15, 2010
Biochemical aspects of X-linked adrenoleukodystrophyStephan Kemp, Ronald Wanders
JAMA Pediatrics|February 10, 2025
Newborn Screening for AdrenoleukodystrophyMarc Engelen, Stephan Kemp
Handbook of Clinical Neurology|July 16, 2021
Endocrine dysfunction in adrenoleukodystrophyMarc Engelen, Stephan Kemp, Florian Eichler
European Journal of Human Genetics : EJHG|November 11, 2011
Clinical utility gene card for: adrenoleukodystrophyErnst Krasemann, Stephan Kemp, Andreas Gal
Molecular Genetics and Metabolism|November 10, 2006
X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatmentStephan Kemp, Ronald J A Wanders
Biochimica Et Biophysica Acta|April 10, 2012
X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspectsStephan Kemp, Johannes Berger, Patrick Aubourg
Handbook of Clinical Neurology|September 25, 2024
AdrenoleukodystrophyMarc Engelen, Stephan Kemp, Florian Eichler
The FEBS Journal|December 16, 2010
Fatty acid omega-oxidation as a rescue pathway for fatty acid oxidation disorders in humansRonald J A Wanders, Jasper Komen, Stephan Kemp
Current Neurology and Neuroscience Reports|August 14, 2014
X-linked adrenoleukodystrophy: pathogenesis and treatmentMarc Engelen, Stephan Kemp, Bwee-Tien Poll-The
Cells|January 21, 2022
Structure and Function of the <i>ABCD1</i> Variant Database: 20 Years, 940 Pathogenic Variants, and 3400 Cases of AdrenoleukodystrophyEric J Mallack, Kerry Gao, Marc Engelen, et al.
Pageof 11